The Use of Complementary and Alternative Medicine (Cam) in the Management of Hiv/Aids

The summary for the The Use of Complementary and Alternative Medicine (Cam) in the Management of Hiv/Aids grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

The Use of Complementary and Alternative Medicine (Cam) in the Management of Hiv/Aids: This initiative will stimulate research to elucidate the mechanisms, risks, and benefits of using complementary and alternative medicine (CAM) in the management of HIV/AIDS at institutions with extensive histories of research on HIV/AIDS (see Eligible Institutions below). NCCAM is especially interested in supporting well-designed studies to identify potential roles for the safe and effective use of CAM in the management of HIV/AIDS and its complications, to ameliorate medication side effects, or improve quality of life.

Federal Grant Title:	The Use of Complementary and Alternative Medicine (Cam) in the Management of Hiv/Aids
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-AT-05-004
Type of Funding:	Grant
CFDA Numbers:	93.213
CFDA Descriptions:	Research and Training in Complementary and Alternative Medicine
Current Application Deadline:	No deadline provided
Original Application Deadline:	Jan 14, 2005
Posted Date:	Sep 22, 2004
Creation Date:	Sep 22, 2004
Archive Date:	Feb 13, 2005
Total Program Funding:	$1,500,000
Maximum Federal Grant Award:	$125,000
Minimum Federal Grant Award:
Expected Number of Awards:	4
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: To be eligible for an award through this solicitation, institutions will be required to have a National Institutes of Health grant for a Center for AIDS Research (CFAR), a Developmental Center for AIDS Research (D-CFAR), or be a unit of an Adult AIDS Clinical Trial Group (AACTG), a Pediatric AIDS Clinical Trial Group (PACTG), or the Community Program for Clinical Research on AIDS (CPCRA) (including affiliate units).
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [email protected] NIH OER Webmaster
Similar Government Grants: • Feasibility Trials of the NIH Music-based Interventions Toolkit for Brain Disorders of Agi...; • Botanical Dietary Supplements Translational Research Teams (RM1 Clinical Trial Required); • Limited Competition: Research Resource for Natural Product Nuclear Magnetic Resonance Data...; • Leveraging Data at Scale to Understand Natural Product Impacts on Whole Person Health (R01...; • Natural Product Multi-Site Clinical Trial Data Coordinating Center (Collaborative U24 Clin...; • Probiotics for Pediatric Illnesses; • Cam Practitioner Research Education Project Grant Partnership; • Complementary and Alternative Medicine Career Transition Award (K22)
More Grants from the National Institutes of Health: • The NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Preven...; • Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional); • Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Tri...; • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...